1)Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003; 13: 3-126
|
|
|
2)網野信行,井手 茜.TSH基準値裏事情.日本甲状腺学会雑誌.2014; 5: 66-9
|
|
|
3)網野信行.妊娠と甲状腺機能―エビデンスと診療ガイドライン.Medical Practice. 2014; 31: 1714-21
|
|
|
4)De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97: 2543-65
|
|
|
5)Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007; 92(Suppl): S1-47
|
|
|
6)Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011; 21: 1081-125
|
|
|
7)日本甲状腺学会,編.バセドウ病治療ガイドライン2011.東京: 南江堂; 2011
|
|
|
8)Amino N, Tada H, Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid. 1999; 9: 705-13
|
|
|
9)Ide A, Amino N, Kang S, et al. Differentiation of postpartum Gravesʼ thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow. Thyroid. 2014; 24: 1027-31
|
|
|
10)網野信行,玉井秀一.生殖医療における甲状腺機能異常.産婦人科治療.2011; 102: 691-8
|
|
|
11)Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010; 31: 702-55
|
|
|
12)Kim CH, Ahn JW, Kang SP, et al. Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2011; 95: 1650-4
|
|
|
13)Lincoln SR, Ke RW, Kutteh WH. Screening for hypothyroidism in infertile women. J Reprod Med. 1999; 44: 455-7
|
|
|
14)Abalovich M, Gutierrez S, Alcaraz G, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002; 12: 63-8
|
|
|
15)Negro R, Formoso G, Mangieri T, et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab. 2006; 91: 2587-91
|
|
|
16)Yoshioka W, Amino N, Ide A, et al. Thyroxine treatment is possibly useful for subclinical hypothyroidism in patients with female infertility. Endocrine J. 2015; 62: 87-92
|
|
|
17)Colicchia M, Campagnolo L, Baldini E, et al. Molecular basis of thyrotropin and thyroid hormone action during implantation and early development. Hum Reprod Update. 2014; 20: 884-904
|
|
|
18)Andersen SL, Olsen J, Wu CS, et al. Severity of birth defects after propylthiouracil exposure in early pregnancy. Thyroid. 2014; 24: 1533-40
|
|
|